C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction

Journal of Experimental Medicine

Volumn 190, Issue 12, 1999, Pages 1733-1739

  Griselli, M ^a   Herbert, J ^a   Hutchinson, W L ^a   Taylor, K M ^a   Sohail, M ^a   Krausz, T ^a   Pepys, M B ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Acute phase response; Heart; Inflammation; Ischemia; Necrosis

Indexed keywords

C REACTIVE PROTEIN; COBROTOXIN; COMPLEMENT; PLASMA PROTEIN;

ACUTE HEART INFARCTION; ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; COMPLEMENT ACTIVATION; CORONARY ARTERY LIGATION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; TISSUE INJURY;

ACUTE DISEASE; ANIMALS; C-REACTIVE PROTEIN; COMPLEMENT ACTIVATION; HUMANS; MYOCARDIAL INFARCTION; RATS;

EID: 0033396705     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.12.1733     Document Type: Article

References (43)

1. Entman, M.L., L. Michael, R.D. Rossen, W.J. Dreyer, D.C. Anderson, A.A. Taylor, and C.W. Smith. 1991. Inflammation in the course of early myocardial ischemia. FASEB J. 5:2529-2537.
2. Väkevä, A., B.P. Morgan, I. Tikkanen, K. Helin, P. Laurila, and S. Meri. 1994. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Am. J. Pathol. 144:1357-1368.
3. Hill, J.H., and P.A. Ward. 1971. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. Exp. Med. 133:885-900.
4. Maclean, D., M.C. Fishbein, E. Braunwald, and P.R. Maroko. 1978. Long-term preservation of ischemic myocardium after experimental coronary artery occlusion. J. Clin. Invest. 61: 541-551.
5. Maroko, P.R., C.B. Carpenter, M. Chiariello, M.C. Fishbein, P. Radvany, J.D. Knostman, and S.L. Hale. 1978. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J. Clin. Invest. 61:661-670.
6. Pinckard, R.N., R.A. O'Rourke, M.H. Crawford, F.S. Grover, L.M. McManus, J.J. Ghidoni, S.B. Storrs, and M.S. Olson. 1980. Complement localization and mediation of ischemic injury in baboon myocardium. J. Clin. Invest. 66: 1050-1056.
7. Crawford, M.H., F.L. Grover, W.P. Kolb, C.A. McMahan, K.A. O'Rourke, L.M. McManus, and R.N. Pinckard. 1988. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation. 78:1449-1458.
8. Weisman, H.F., T. Bartow, M.K. Leppo, H.C. Marsh, G.R. Carson, M.F. Concino, M.P. Boyle, K.H. Roux, M.L. Weisfeldt, and D.T. Fearon. 1990. Soluble human complement receptor type 1 : in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 249:146-151.
9. Lucchesi, B.R., and K.S. Kilgore. 1997. Complement inhibitors in myocardial ischemia/reperfusion injury. Immunopharmacology. 38:27-42.
10. Kushner, I., M.L. Broder, and D. Karp. 1978. Control of the acute hase response. Serum C-reactive protein kinetics after acute myocardial infarction. J. Clin. Invest. 61:235-242.
11. de Beer, F.C., C.R.K. Hind, K.M. Fox, R. Allan, A. Maseri, and M.B. Pepys. 1982. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br. Heart J. 47:239-243.
12. Ueda, S., U. Ikeda, K. Yamamoto, M. Takahashi, M. Nishinaga, N. Nago, and K. Shimada. 1996. C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction. Am. Heart J. 131:857-860.
13. Pietilä, K.O., A.P. Harmoinen, J. Jokiniitty, and A.I. Pasternack. 1996. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur. Heart J. 17:1345-1349.
14. Kushner, I., L. Rakica, and M.H. Kaplan. 1963. Studies of acute phase protein. II. Localization of Cx-reactive protein in heart in induced myocardial infarction in rabbits. J. Clin. Invest. 42:286-292.
15. Lagrand, W.K., H.W.M. Niessen, G.-J. Wolbink, L.H. Jaspars, C.A. Visser, F.W.A. Verheugt, C.J.L.M. Meijer, and C.E. Hack. 1997. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation. 95:97-103.
16. Kaplan, M.H., and J.E. Volanakis. 1974. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J. Immunol. 112:2135-2147.
17. Siegel, J., R. Rent, and H. Gewurz. 1974. Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera. J. Exp. Med. 140:631-647.
18. Volanakis, J.E., and M.H. Kaplan. 1974. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea-pig complement by CRP complexes: requirement for human C1q. J. Immunol. 113:9-17.
19. Volanakis, J.E. 1982. Complement activation by C-reactive protein complexes. Ann. NY Acad. Sci. 389:235-250.
20. Jiang, H., F.A. Robey, and H. Gewurz. 1992. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain. J. Exp. Med. 175:1373-1379.
21. Pepys, M.B. 1981. C-reactive protein fifty years on. Lancet. 1:653-657.
22. Pepys, M.B. 1982. C-reactive protein, amyloidosis and the acute phase response. The Goulstonian Lecture. In Advanced Medicine, Vol. 18. M. Sarner, editor. Pitman Books Ltd., Tunbridge Wells, UK. 208-230.
23. 2 and C-reactive protein in the removal of injured cells. Immunol. Today. 18:111-115.
24. Beranek, J.T. 1997. C-reactive protein and complement in myocardial infarction and postinfarction heart failure. Eur. Heart J. 18:1834-1835.
25. Beranek, J.T. 1998. C-reactive protein in postinfarction heart rupture. Am. Heart J. 136:563-564.
26. Vigushin, D.M., M.B. Pepys, and P.N. Hawkins. 1993. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J. Clin. Invest. 91: 1351-1357.
27. Hawkins, P.N., R. Wootton, and M.B. Pepys. 1990. Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. J. Clin. Invest. 86:1862-1869.
28. de Beer, F.C., M.L. Baltz, E.A. Munn, A. Feinstein, J. Taylor, C. Bruton, J.R. Clamp, and M.B. Pepys. 1982. Isolation and characterisation of C-reactive protein and serum amyloid P component in the rat. Immunology. 45:55-70.
29. Pepys, M.B., C. Tompkins, and A.D. Smith. 1979. An improved method for the isolation from Naja naja venom of cobra factor (CoF) free of phospholipase A. J. Immunol. Methods. 30:105-117.
30. Pepys, M.B., and M.L. Baltz. 1983. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34:141-212.
31. Pepys, M.B. 1995. The acute phase response and C-reactive protein. In Oxford Textbook of Medicine, 3rd ed., Vol. 2. D.J. Weatherall, J.G.G. Ledingham, and D.A. Warrell, editors. Oxford University Press, Oxford, UK. 1527-1533.
32. Nelson, S.R., G.A. Tennent, D. Sethi, P.E. Gower, F.W. Ballardie, S. Amatayakul-Chantler, and M.B. Pepys. 1991. Serum amyloid P component in chronic renal failure and dialysis. Clin. Chim. Acta. 200:191-200.
33. Pepys, M.B. 1975. Studies in vivo of cobra factor and murine C3. Immunology. 28:369-377.
34. Du Clos, T.W. 1999. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J. Immunol. 143:2553-2559.
35. Pepys, M.B., S.E. Booth, G.A. Tennent, P.J.G. Butler, and D.G. Williams. 1994. Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli. Clin. Exp. Immunol. 97:152-157.
36. Pepys, M.B., A.C. Dash, T.C. Fletcher, N. Richardson, E.A. Munn, and A. Feinstein. 1978. Analogues in other mammals and in fish of human plasma proteins C-reactive protein and amyloid P component. Nature. 273:168-170.
37. Baltz, M.L., F.C. de Beer, A. Feinstein, E.A. Munn, C.P. Milstein, T.C. Fletcher, J.F. March, J. Taylor, C. Bruton, J.R. Clamp, et al. 1982. Phylogenetic aspects of C-reactive protein and related proteins. Ann. NY Acad. Sci. 389:49-75.
38. Mold, C., S. Nakayama, T.J. Holzer, H. Gewurz, and T.W. Du Clos. 1981. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J. Exp. Med. 154:1703-1708.
39. Yother, J., J.E. Volanakis, and D.E. Briles. 1982. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice. J. Immunol. 128:2374-2376.
40. Weiser, J.N., N. Pan, K.L. McGowan, D. Musher, A. Martin, and J. Richards. 1998. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 187: 631-640.
41. Bickerstaff, M.C.M., M. Botto, W.L. Hutchinson, J. Herbert, G.A. Tennent, A. Bybee, D.A. Mitchell, H.T. Cook, P.J.G. Butler, M.J. Walport, et al. 1999. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5:694-697.
42. Pepys, M.B. 1999. The Lumleian Lecture. C-reactive protein and amyloidosis: from proteins to drugs? In Horizons in Medicine, Vol. 10. G. Williams, editor. Royal College of Physicians, London. 397-414.
43. Thompson, D., M.B. Pepys, and S.P. Wood. 1999. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure. 7:169-177.